58 related articles for article (PubMed ID: 8419190)
1. Comparison of three different forms of HLA-DR4Dw4 proteins.
Buelow R; Paborsky LR; van Schooten WC; Kummerehl TJ; Schreifels R; Marshall K; Mayer J; Rothbard JB
Eur J Immunol; 1993 Jan; 23(1):69-76. PubMed ID: 8419190
[TBL] [Abstract][Full Text] [Related]
2. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
[TBL] [Abstract][Full Text] [Related]
3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
4. Purified HLA class II peptide complexes can induce adherence and activation of peptide-specific human T cell clones.
van Schooten WC; Maiore T; Jones KR; Paborsky L
J Immunol; 1992 Feb; 148(4):1043-8. PubMed ID: 1531349
[TBL] [Abstract][Full Text] [Related]
5. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
[TBL] [Abstract][Full Text] [Related]
6. Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity.
Chaves FA; Hou P; Wu S; Sant AJ
J Immunol Methods; 2005 May; 300(1-2):74-92. PubMed ID: 15896797
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells.
Hansen BE; Andersson EC; Madsen LS; Engberg J; Søndergaard L; Svejgaard A; Fugger L
Tissue Antigens; 1998 Feb; 51(2):119-28. PubMed ID: 9510368
[TBL] [Abstract][Full Text] [Related]
8. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
Hill CM; Hayball JD; Allison AA; Rothbard JB
J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
[TBL] [Abstract][Full Text] [Related]
9. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
Signorelli KL; Watts LM; Lambert LE
Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
[TBL] [Abstract][Full Text] [Related]
10. Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells.
Wallny HJ; Sollami G; Karjalainen K
Eur J Immunol; 1995 May; 25(5):1262-6. PubMed ID: 7774629
[TBL] [Abstract][Full Text] [Related]
11. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
12. Immobilized staphylococcal enterotoxin A is sufficient to induce T cell proliferation.
Rust CJ; Koning F; van Schooten WC
Cell Immunol; 1993 Oct; 151(2):467-73. PubMed ID: 8402950
[TBL] [Abstract][Full Text] [Related]
13. MHC class II binding of peptides derived from HLA-DR 1.
Harris PE; Liu Z; Suciu-Foca N
J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
[TBL] [Abstract][Full Text] [Related]
14. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
[TBL] [Abstract][Full Text] [Related]
15. Peptide binding to soluble HLA-DR4 molecules produced by insect cells.
Scheirle A; Takacs B; Kremer L; Marin F; Sinigaglia F
J Immunol; 1992 Sep; 149(6):1994-9. PubMed ID: 1387668
[TBL] [Abstract][Full Text] [Related]
16. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells.
Ceppellini R; Frumento G; Ferrara GB; Tosi R; Chersi A; Pernis B
Nature; 1989 Jun; 339(6223):392-4. PubMed ID: 2786148
[TBL] [Abstract][Full Text] [Related]
17. Characterization of B- and T-cell responses and HLA-DR4 binding motifs of the latex allergen Hev b 6.01 (prohevein) and its post-transcriptionally formed proteins Hev b 6.02 and Hev b 6.03.
Raulf-Heimsoth M; Rozynek P; Brüning T; Rihs HP
Allergy; 2004 Jul; 59(7):724-33. PubMed ID: 15180759
[TBL] [Abstract][Full Text] [Related]
18. A DR17-restricted T cell epitope from a secreted Mycobacterium tuberculosis antigen only binds to DR17 molecules at neutral pH.
Geluk A; van Meijgaarden KE; de Vries RR; Sette A; Ottenhoff TH
Eur J Immunol; 1997 Apr; 27(4):842-7. PubMed ID: 9130633
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
[TBL] [Abstract][Full Text] [Related]
20. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13.
Hastings AE; Hurley CK; Robinson ED; Salerno K; Hernandez E; Richert JR
J Immunol; 1996 Oct; 157(8):3460-71. PubMed ID: 8871645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
